Epigral Ltd. (EPIGRAL) - Total Liabilities

Latest as of March 2026: Rs12.84 Billion INR ≈ $138.85 Million USD

Based on the latest financial reports, Epigral Ltd. (EPIGRAL) has total liabilities worth Rs12.84 Billion INR (≈ $138.85 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore EPIGRAL net assets growth trend to track the company's year-over-year net asset growth rate.

Epigral Ltd. - Total Liabilities Trend (2015–2026)

This chart illustrates how Epigral Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See Epigral Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Epigral Ltd. Competitors by Total Liabilities

The table below lists competitors of Epigral Ltd. ranked by their total liabilities.

Company	Country	Total Liabilities
Lu Thai Textile Co Ltd SHE:000726	China	CN¥4.10 Billion
Care Property Invest NV BR:CPINV	Belgium	€674.10 Million
Guangdong Shirongzhaoye Co Ltd SHE:002016	China	CN¥2.75 Billion
Zhewen Pictures Group Co Ltd SHG:601599	China	CN¥1.99 Billion
SD Biosensor Inc KO:137310	Korea	₩914.08 Billion
Smith & Wesson Brands Inc NASDAQ:SWBI	USA	$185.39 Million
Dat Xanh Real Estate Service Contructions Corp VN:DXG	Vietnam	₫17.39 Trillion
Martinrea International Inc. TO:MRE	Canada	CA$2.34 Billion

Liability Composition Analysis (2015–2026)

This chart breaks down Epigral Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Epigral Ltd. market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.16	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.58	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Epigral Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Epigral Ltd. (2015–2026)

The table below shows the annual total liabilities of Epigral Ltd. from 2015 to 2026.

Year	Total Liabilities	Change
2026-03-31	Rs12.84 Billion ≈ $138.85 Million	+2.88%
2025-03-31	Rs12.48 Billion ≈ $134.96 Million	-18.98%
2024-03-31	Rs15.40 Billion ≈ $166.57 Million	+12.99%
2023-03-31	Rs13.63 Billion ≈ $147.42 Million	-2.47%
2022-03-31	Rs13.98 Billion ≈ $151.16 Million	+82.81%
2021-03-31	Rs7.65 Billion ≈ $82.69 Million	+10.81%
2020-03-31	Rs6.90 Billion ≈ $74.62 Million	+25.12%
2019-03-31	Rs5.51 Billion ≈ $59.64 Million	+259.21%
2018-03-31	Rs1.54 Billion ≈ $16.60 Million	-7.43%
2017-03-31	Rs1.66 Billion ≈ $17.93 Million	-32.24%
2016-03-31	Rs2.45 Billion ≈ $26.47 Million	-22.05%
2015-03-31	Rs3.14 Billion ≈ $33.96 Million	--

About Epigral Ltd.

NSE:EPIGRAL India Chemicals

Market Cap

$522.87 Million

Rs48.35 Billion INR

Market Cap Rank

#11849 Global

#601 in India

Share Price

Rs1120.70

Change (1 day)

+2.94%

52-Week Range

Rs810.45 - Rs1918.90

All Time High

Rs2344.35